Sectors
OSCR
Oscar Health, Inc.
27.39
1 x 27.20
2 x 27.59
bid
ask
-
0.28
1.01%
09:40 AM
timesize
| Ytd | 90.61% | |
| 1y | 75.46% |
27.16
day range
27.67
10.69
52 week range
33.10
| Open | 27.48 | Prev Close | 27.67 | Low | 27.16 | High | 27.67 | Mkt Cap | 7.08B |
| Vol | 193.20K | Avg Vol | 6.71M | EPS | 1.40 | P/E | 19.51 | Forward P/E | 16.26 |
| Beta | 2.36 | Short Ratio | 3.33 | Inst. Own | 67.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 28.73 | 200-d Avg | 19.17 | 1yr Est | 28.20 |
| Income Statement | |||
| Total Revenue | 4.88B | ||
| Revenues (USD) | 4.88B | ||
| Cost of Revenue | 3.79B | ||
| Gross Profit | 1.09B | ||
| Operating Expenses | 697.14M | ||
| Selling, General and Administrative Expense | 691.08M | ||
| Operating Income | 388.64M | ||
| Interest Expense | 4.71M | ||
| Income Tax Expense | 21.18M | ||
| Net Income | 361.81M | ||
| Net Income Common Stock | 361.81M | ||
| Net Income Common Stock (USD) | 361.81M | ||
| Consolidated Income | 361.83M | ||
| Net Income to Non-Controlling Interests | 20.00K | ||
| Earnings per Basic Share | 1.20 | ||
| Earnings per Basic Share (USD) | 1.20 | ||
| Earnings per Diluted Share | 1.10 | ||
| Earning Before Interest & Taxes (EBIT) | 387.70M | ||
| Earning Before Interest & Taxes (USD) | 387.70M | ||
| Weighted Average Shares | 302.22M | ||
| Weighted Average Shares Diluted | 333.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.08B | ||
| Cash and Equivalents (USD) | 4.08B | ||
| Investments | 6.11B | ||
| Investments Current | 4.48B | ||
| Investments Non-Current | 1.63B | ||
| Trade and Non-Trade Receivables | 757.35M | ||
| Current Assets | 9.37B | ||
| Property, Plant & Equipment Net | 101.49M | ||
| Total Assets | 11.23B | ||
| Total Debt | 431.63M | ||
| Current Liabilities | 8.69B | ||
| Debt Non-Current | 431.63M | ||
| Total Liabilities | 9.17B | ||
| Accumulated Retained Earnings (Deficit) | -2.25B | ||
| Accumulated Other Comprehensive Income | -8.25M | ||
| Shareholders Equity | 2.05B | ||
| Shareholders Equity (USD) | 2.05B | ||
| Assets Non-Current | 1.85B | ||
| Total Debt (USD) | 431.63M | ||
| Deferred Revenue | 167.51M | ||
| Liabilities Non-Current | 482.10M | ||
| Trade and Non-Trade Payables | 8.52B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.03M | ||
| Net Cash Flow from Financing | 13.30M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -728.97M | ||
| Capital Expenditure | -11.76M | ||
| Issuance (Purchase) of Equity Shares | 28.77M | ||
| Issuance (Repayment) of Debt Securities | -180.00K | ||
| Net Cash Flow from Investing | -2.83B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.82B | ||
| Net Cash Flow from Operations | 2.09B | ||
| Share Based Compensation | 20.65M | ||